Yıldız, S. Et Al. 2025. Use of Sodium Glucose Cotransporter-2 Inhibitor and Thiol Disulfide Homeostasis in Type -2 Diabetic Patients. Eastern Journal of Medicine , vol.30, no.3 , 417-425.

Yıldız, S., Akgündüz, M. A., NEŞELİOĞLU, S., EREL, Ö., & Alay, M., (2025). Use of Sodium Glucose Cotransporter-2 Inhibitor and Thiol Disulfide Homeostasis in Type -2 Diabetic Patients. Eastern Journal of Medicine , vol.30, no.3, 417-425.

Yıldız, Saliha Et Al. "Use of Sodium Glucose Cotransporter-2 Inhibitor and Thiol Disulfide Homeostasis in Type -2 Diabetic Patients," Eastern Journal of Medicine , vol.30, no.3, 417-425, 2025

Yıldız, Saliha Et Al. "Use of Sodium Glucose Cotransporter-2 Inhibitor and Thiol Disulfide Homeostasis in Type -2 Diabetic Patients." Eastern Journal of Medicine , vol.30, no.3, pp.417-425, 2025

Yıldız, S. Et Al. (2025) . "Use of Sodium Glucose Cotransporter-2 Inhibitor and Thiol Disulfide Homeostasis in Type -2 Diabetic Patients." Eastern Journal of Medicine , vol.30, no.3, pp.417-425.

@article{article, author={Saliha Yıldız Et Al. }, title={Use of Sodium Glucose Cotransporter-2 Inhibitor and Thiol Disulfide Homeostasis in Type -2 Diabetic Patients}, journal={Eastern Journal of Medicine}, year=2025, pages={417-425} }